MedTrace Logo

Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome

NCT00806182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-05-23

No results posted yet for this study

Summary

The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic targets in children with opsoclonus-myoclonus syndrome (OMS), an autoimmune complication of the tumor neuroblastoma.

Conditions

  • Opsoclonus-myoclonus Syndrome

Sponsors & Collaborators

  • National Pediatric Neuroinflammation Organization, Inc.

    lead OTHER

Principal Investigators

  • Michael R Pranzatelli, MD · National Pediatric Neuroinflammation Organization, Inc.

  • Elizabeth D Tate, FNP, MN · National Pediatric Neuroinflammation Organization, Inc.

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00806182 on ClinicalTrials.gov